Healthcare Cost Analysis, Bereavement and Frailty, and more
Read a healthcare cost analysis for patients taking ixekizumab compared to secukinumab or adalimumab, as well as about bereavement and frailty, and more.
Read a healthcare cost analysis for patients taking ixekizumab compared to secukinumab or adalimumab, as well as about bereavement and frailty, and more.
The developed scale strengthens the investigation of global irritable bowel disease epidemiology.
The new blood test is less invasive and more accessible to patients.
Higher HbA1c levels were a higher risk factor in children with lower BMIs.
Ifetroban shows significant 12-month cardiac benefit in DMD patients, per phase-2 FIGHT DMD trial results.
Apitegromab improves motor function in SMA patients aged 2–21, per phase-3 SAPPHIRE trial results.
A troubling rise in sun exposure and inconsistent sunscreen use may be linked to incidence of skin cancer in Canada.
Losmapimod failed to show clinical benefit over placebo in FSHD patients in the phase 3 REACH trial, ending its development.
Intrathecal gene therapy OA significantly improved motor function in older SMA patients in phase-3 STEER trial.
Individuals with TSW had elevated levels of a form of vitamin B3, causing inflammation separate from eczema symptoms.
There have been 12 outbreaks in 2025 so far, defined as three or more related cases.